Chad Therapeutics Notes Quarterly Loss of $679,000

Chad Therapeutics Inc., Chatsworth, reported losses of $679,000 for the fourth quarter that ended March 31, compared with losses of $10,000 for the same quarter last year. Sales were $3 million, down 15%.

For the year, losses were $1.5 million, compared with earnings of $797,000 for the previous year.

Chad Therapeutics produces and distributes oxygen-conserving devices and oxygen systems for medical use.